‘Brexit taskforce’ will see Recipharm prioritise its preparations and invest in the necessary capabilities and equipment to ensure seamless operations post March 2019.31 May 2018
Forgotten markets of Africa and Arabia to see increased growth fuelled by international and domestic partnerships and imported APIs.30 May 2018
The Wear Indicator Layer is expected to have a "huge impact" on customers' production.7 Jun 2018
Much needed more efficient manufacturing processes for ADCs aren't being completed by pharma.Read more
Company to streamline operations and capture cost synergies.Read more
Money to be spent on augmenting capability and capacity for process development and scale up, handling of potent substances, crystallization studies and solid phase characterization.Read more
NURONORM, is a combination of natural elements, based on Alpha-Lipoic acid, Carnosine, Zinc and Vitamin B with clinical trials showing efficacy in the prevention and treatment of (diabetic) neuropathy. NURONORM® can also be used in Peripheral Neuropathies: due to compression, trauma, inflammation, resulti...Read more
Corticosteroids productsClobetasol Propionate 0.05%This products are used in short courses to treat inflammatory skin conditions such as
Eczema of various types.Skin inflammation due to allergies or irritants (allergic contact dermatitis orirritant contact dermatitis).Inflammatory skin co...
Ingredient: Levonorgestrel 1.5 mg
Dosage Form: Tablet
Indication: Emergency Oral ContraceptivesbrhrbrSynmosa Group offers a wide range of oral contraceptive products which includes anlitin. Indication: emergency oral contraceptives. Dosage: 1 tab as soon as poss...
Collaboration to provide GMP-based services19 Jun 2018
Johnson Matthey wins Company of the Year 2018 at UK Chemical Industries Association Awards19 Jun 2018
Diverse, effective and unique - an Interview with CG Chemikalien’s director Uwe Klass about advantages of the new “Pharma & Nutrition” division19 Jun 2018
We have successfully developed a number of transdermal patches for indications including Alzheimer's, Parkinsons, and Hypertension and offer an end to end solution for licensees for old and new drugs intended for delivery through transdermal patches.Read more
ANTI-HAIRLOSS PATCH, a unique new concept which fights hair loss, especially that of an androgenic nature but also when it is due to stress or fatigue. Its components directly impact hair formation and blood circulation at the scalp level, thus preventing weaker hair to be lost. The patch is a new applic...Read more
VetaFilm™ is our proprietary veterinary oral film technology that provides significant market
opportunities for improving drug delivery for companion animals.
VetaFilm ™ research and development services and veterinary oral films provide:
A third generation topical patch for the management of pain and inflammation. - Long half life; once daily dosage with relatively shorter administration period provides efficacy with less skin irritation/inflammation. - Patch is non-hydrogel, alcohol-free formulation.- Patch matrix formulation is only 0...Read more
Sandoz GmbH offers wide range of products which includes transdermal patches. It is an innovative alternative for controlled drug delivery through the skin and into the bloodstream. Contact us for more information.Read more
DIFOPREV® Daily, is a sock for daily use with beneficial properties for the correct care of the diabetic foot. These socks are able to transfer to the feet the health and safe properties of F.I.R. (Fast Infrared Radiaton), which increases levels of nitric oxide, vasodilation, oxygenation a...Read more
Symptomatic treatment of mild to
moderately severe Alzheimer’s dementia.
Recipharm offer formulation development services for all dosage forms. We develop everything from simple formulations for early studies to more complex formulations suited for commercialisation.Read more
CDMO for transdermal patches and oral/buccal films, not only for small molecules, but also for macromolecular biopharmaceuticalsRead more
USP/NF: Amino Methacrylate Co-polymer
Ph. Eur: Basic Butylated Methacrylate Co-polymer
10.00 kg net in paper finer drum with polyethylene lining.
Moderate to severe cancer pain
and severe pain which does not respond to non-opioid analgesics.
Buprenorphin is not suitable for the treatment of acute pain.
IntelGenx offers full service to foster the growth of its partners.
Our State-of-the-art facilities are equipped with the most modem equipment to deliver high-quality, cost-effective film products, while accommodating client requirements at each stage of product development.
DIFOPREV® is a ready and easy to use system, designed speciﬁcally for the prevention of the Diabetic Foot complication. It consists of a starter kit including a pair of rechargeable socks and associated refill capsules for a monthly treatment.
For Adults: Indicated for
management of severe chronic pain that requires continuous long term opioid
For Children: Long term management of severe chronic pain in children from 2 years of age who are receiving opioid therapy.
VersaFilm™ is our proprietary delivery technology platform that enables the development of pharmaceutical films with potential to improve product performance:
A Proprietary micro-injector system for delivering liquid injectables through the skin to different controlled depths. This technology has been developed in conjunction with reformulations of Sumatriptan for Migraine, and Fentanyl for BTP, amongst a number of other small and large molecules currently in devel...Read more
A proprietary injector system that allows solid particles or drug coatings on needles to be instantly released into the skin using a low cost disposable applicator. Drugs such as Teriparatide and some vaccines are currently in development using this technology platform.Read more
The log-in process has been changed. If you have trouble logging into your company profile please click here.